|
CN107001379B
(zh)
|
2014-11-06 |
2022-11-01 |
Bial研发投资股份有限公司 |
取代的吡唑并[1,5-a]嘧啶以及它们在治疗医学障碍中的用途
|
|
WO2016073889A1
(en)
|
2014-11-06 |
2016-05-12 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
AU2015342883B2
(en)
|
2014-11-06 |
2020-07-02 |
Bial - R&D Investments, S.A. |
Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders
|
|
US10787454B2
(en)
|
2016-04-06 |
2020-09-29 |
BIAL—BioTech Investments, Inc. |
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
WO2017176962A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics, Inc. |
Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
WO2017176960A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics Inc. |
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
MX389579B
(es)
|
2016-05-05 |
2025-03-20 |
Bial R&D Invest S A |
IMIDAZO[1,2-b]PIRIDAZINAS SUSTITUIDAS, IMIDAZO[1,5-b]PIRIDAZINAS SUSTITUIDAS, COMPUESTOS RELACIONADOS Y SU USO EN EL TRATAMIENTO DE TRASTORNOS MÉDICOS
|
|
KR102531036B1
(ko)
|
2016-10-07 |
2023-05-09 |
브리스톨-마이어스 스큅 컴퍼니 |
Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물
|
|
US11299494B2
(en)
|
2016-11-17 |
2022-04-12 |
Bristol-Myers Squibb Company |
Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators
|
|
WO2019023468A1
(en)
*
|
2017-07-28 |
2019-01-31 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
US10508113B2
(en)
|
2018-03-12 |
2019-12-17 |
Abbvie Inc. |
Inhibitors of tyrosine kinase 2 mediated signaling
|
|
ES2938751T3
(es)
*
|
2018-09-10 |
2023-04-14 |
Lilly Co Eli |
Derivados de pirazol[1,5-a]pirimidina-3-carboxamida útiles en el tratamiento de la psoriasis y el lupus eritematoso sistémico
|
|
HRP20250048T1
(hr)
|
2018-10-22 |
2025-03-28 |
Alumis Inc. |
Inhibitori tyk2 i njihova uporaba
|
|
AR117177A1
(es)
*
|
2018-12-10 |
2021-07-14 |
Lilly Co Eli |
DERIVADOS DE 7-(METILAMINO)PIRAZOLO[1,5-A]PIRIMIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE IL-23 E INFa
|
|
TW202214648A
(zh)
*
|
2019-01-07 |
2022-04-16 |
美商美國禮來大藥廠 |
Il-17a抑制劑
|
|
AU2020212001A1
(en)
*
|
2019-01-23 |
2021-07-22 |
Takeda Pharmaceutical Company Limited |
TYK2 inhibitors and uses thereof
|
|
MX2021009555A
(es)
*
|
2019-02-07 |
2021-10-13 |
Ventyx Biosciences Inc |
Ligandos de pseudocinasa tyk2.
|
|
WO2020180907A1
(en)
*
|
2019-03-05 |
2020-09-10 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
IL286248B2
(en)
*
|
2019-03-11 |
2025-12-01 |
Alumis Inc |
Tyk2 inhibitors and uses thereof
|
|
US12516063B2
(en)
|
2020-02-12 |
2026-01-06 |
Eli Lilly And Company |
Substituted 7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives for treating autoimmune diseases
|
|
AR121251A1
(es)
*
|
2020-02-12 |
2022-05-04 |
Lilly Co Eli |
Compuestos de 7-(metilamino)pirazolo[1,5-a]pirimidina-3-carboxamida
|
|
KR20230019507A
(ko)
|
2020-04-30 |
2023-02-08 |
얀센 파마슈티카 엔.브이. |
Il-17의 조절제로서의 이미다조피리다진
|
|
WO2021220183A1
(en)
*
|
2020-04-30 |
2021-11-04 |
Janssen Pharmaceutica Nv |
Imidazopyrimidines as modulators of il-17
|
|
EP3944859A1
(en)
|
2020-07-30 |
2022-02-02 |
Assistance Publique Hôpitaux de Paris |
Method for treating immune toxicities induced by immune checkpoint inhibitors
|
|
WO2022037694A1
(zh)
*
|
2020-08-20 |
2022-02-24 |
轶诺(浙江)药业有限公司 |
一类五元并六元杂环化合物及其作为蛋白受体激酶抑制剂的用途
|
|
WO2022060973A1
(en)
*
|
2020-09-16 |
2022-03-24 |
Alumis, Inc. |
Tyk2 inhibitors and uses thereof
|
|
CN117043164A
(zh)
*
|
2021-01-19 |
2023-11-10 |
安锐生物医药科技(广州)有限公司 |
咪唑并哒嗪或吡唑并嘧啶化合物和组合物
|
|
CN117083268B
(zh)
|
2021-03-16 |
2024-07-30 |
安锐生物医药科技(广州)有限公司 |
氨基杂芳基化合物和组合物
|
|
EP4423086A1
(en)
|
2021-10-25 |
2024-09-04 |
Kymera Therapeutics, Inc. |
Tyk2 degraders and uses thereof
|
|
CN118159524B
(zh)
*
|
2022-01-28 |
2024-12-17 |
和记黄埔医药（上海）有限公司 |
咪唑并[1,2-b]哒嗪类化合物的中间体的合成方法
|
|
WO2025168035A1
(zh)
*
|
2024-02-07 |
2025-08-14 |
合肥羿科医药有限公司 |
杂环类化合物、其药物组合物及其应用
|